These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32162138)

  • 1. A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor.
    Chen W; Boras B; Sung T; Yu Y; Zheng J; Wang D; Hu W; Spilker ME; D'Argenio DZ
    J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):163-182. PubMed ID: 32162138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A whole-body circulatory neutrophil model with application to predicting clinical neutropenia from in vitro studies.
    Chen W; Boras B; Sung T; Hu W; Spilker ME; D'Argenio DZ
    CPT Pharmacometrics Syst Pharmacol; 2021 Jul; 10(7):671-683. PubMed ID: 33793091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony-Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation.
    Chen W; Boras B; Sung T; Hu W; Spilker ME; D'Argenio DZ
    AAPS J; 2020 Nov; 22(6):143. PubMed ID: 33156437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.
    Scholz M; Schirm S; Wetzler M; Engel C; Loeffler M
    Theor Biol Med Model; 2012 Jul; 9():32. PubMed ID: 22846180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modelling of neutrophil response to G-CSF in healthy subjects and patients with chemotherapy-induced neutropenia.
    Melhem M; Delor I; Pérez-Ruixo JJ; Harrold J; Chow A; Wu L; Jacqmin P
    Br J Clin Pharmacol; 2018 May; 84(5):911-925. PubMed ID: 29318653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
    Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of concomitant use of G-CSF and myelosuppressive chemotherapy on bone marrow and peripheral granulocytes in a mouse model.
    Endo Y; Ishikawa T; Oka K; Sakakida T; Matsumura S; Mizushima K; Doi T; Okayama T; Katada K; Kamada K; Uchiyama K; Takagi T; Fujiwara H; Konishi H; Naito Y; Itoh Y
    Med Oncol; 2022 Jun; 39(8):110. PubMed ID: 35666320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) augments the therapeutic effect of pegfilgrastim on gemcitabine-induced neutropenia.
    Yoo N; Lee HR; Shin SH; Sohn KY; Kim HJ; Han YH; Chong S; Kim MH; Yoon SY; Kim JW
    Cancer Lett; 2016 Jul; 377(1):25-31. PubMed ID: 27105612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) expression in bone marrow and fractionated marrow cell populations by interleukin 3 (IL-3): IL-3-mediated positive feedback mechanisms of granulopoiesis.
    Tsuji T; Sugimoto K; Yanai T; Takashita E; Mori KJ
    Growth Factors; 1994; 11(1):71-9. PubMed ID: 7530467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies.
    Hu W; Sung T; Jessen BA; Thibault S; Finkelstein MB; Khan NK; Sacaan AI
    Clin Cancer Res; 2016 Apr; 22(8):2000-8. PubMed ID: 26631614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of granulocyte colony-stimulating factor on granulopoiesis of congenital neutropenic children.
    Benkö I; Maródi L; Megyeri A; Káposzta R; Kovács P
    Acta Physiol Hung; 1996; 84(3):261-2. PubMed ID: 9219597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.
    Lieschke GJ; Grail D; Hodgson G; Metcalf D; Stanley E; Cheers C; Fowler KJ; Basu S; Zhan YF; Dunn AR
    Blood; 1994 Sep; 84(6):1737-46. PubMed ID: 7521686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy.
    Hansen PB; Johnsen HE; Ralfkiaer E; Hansen NE
    Br J Haematol; 1993 Aug; 84(4):581-5. PubMed ID: 7692936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegfilgrastim.
    Willis F; Pettengell R
    Expert Opin Biol Ther; 2002 Dec; 2(8):985-92. PubMed ID: 12517276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy.
    Crawford J
    Pharmacotherapy; 2003 Aug; 23(8 Pt 2):15S-19S. PubMed ID: 12921218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats.
    Scholz M; Engel C; Apt D; Sankar SL; Goldstein E; Loeffler M
    Cell Prolif; 2009 Dec; 42(6):823-37. PubMed ID: 19780759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.
    Lane SW; Crawford J; Kenealy M; Cull G; Seymour JF; Prince HM; Marlton P; Gill D; Mollee PN
    Leuk Lymphoma; 2006 Sep; 47(9):1813-7. PubMed ID: 17064993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow endogenous colony stimulating factor(s): relation to granulopoiesis in vivo.
    Francis GE; Rhodes EG; Berney JJ; Wing MA; Hoffbrand AV
    Exp Hematol; 1981 Apr; 9(4):332-45. PubMed ID: 6972318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
    Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
    Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.